Biomarin Pharma

BRINEURA

Manufacturer:

Biomarin Pharma

Brineura HCPCS:

J0567

HCPCS Code Descriptor:

Injection, cerliponase alfa, 1 mg

Category:

J Code

Brineura NDCs:

68135-0811-02

Primary Type:

Unclassified

Generic/Specialty Status:

Single-Source

Route of Administration:

Multiple Routes

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Brineura:

BRINEURA is an Unclassified drug manufactured by Biomarin Pharma and administered via the Multiple Routes route of administration. The J Code: J0567 is aligned to the drug BRINEURA.

ACCESS PRICING AND MORE BY REGISTERING

J0567 Added Date:

January 1, 2019

J0567 Effective Date:

January 1, 2019

J0567 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Brineura billing and coding information.
Brineura patient assistance information can be found through BioMarin RareConnections at the URL: https://www.biomarin-rareconnections.com/
BRINEURA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for BRINEURA. Please check back in a few weeks.